PwC: Faster Approvals Could Help Hospital-Owned Generic-Drug Maker Avert Shortages, Price Spikes

September 11, 2018
Faster FDA generic drug approvals could help a group of hospitals that are creating their own generic drug making company avoid shortages and price spikes, according to a report by PwC’s Health Research Institute. Most of the attention in the debate over rising drug prices has been on brands, but there have also been cases of price spikes for generics when companies drop out of the market and leave a sole maker. FDA Commissioner Scott Gottlieb says the agency can...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.